Vol 61, No 10 (2004)
Other
Published online: 2005-12-12
Submitted: 2012-12-28
Get Citation

Microcoil embolisation for ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy

Mihai Iacob, Florina Pinte, Ion Tintoiu, Lucretia Cotuna, Mirela Caroescu, Alexandru Popa, Gabriel Cristian, Viorel Goleanu, Vasile Greere, Ion Moscaliuc, Gheorghe Neagoe, Puiu Crisan, Adriana Garjeu, Liviu Chiriac, Romi Bolohan, Vasile Murgu, Beatrice Lobont, Simon Filip, Jean Roates, Gabriel Hila, Elena Postolea
Kardiol Pol 2004;61(10):355-355.
Vol 61, No 10 (2004)
Other
Published online: 2005-12-12
Submitted: 2012-12-28

Abstract

Background and aim: Percutaneous transcatheter occlusion with ethanol injection of septal arteries is an efficient treatment procedure of hypertrophic obstructive cardiomyopathy (HOCM). The aim of our study was to evaluate the feasibility and efficiency of septal artery embolisation with microcoils.
Methods: Microcoils were delivered through the guide-wire lumen of a 2mm-diameter coaxial balloon positioned inside the target vessel as distally as possible. One or more 0.018"-straight microcoils (Hilal straight coils, Cook, USA) were used for each target vessel until complete flow obstruction was achieved. The intraventricular pressure gradient was measured before, during and after the procedure. Septal branch occlusion was finally documented by coronary angiography.
Results: We treated 7 patients (5 males; mean age: 48±10 years). All patients were symptomatic (NYHA class III or IV). The target vessels were successfully occluded in all patients without complications. Moderate pain was recorded during and after the procedure and the CK level increased five- to ten-fold. The pressure gradient diminished during the procedure from 72±21 mmHg to 30±15 mmHg. The number of coils delivered ranged from 3 to 7 per patient. The embolised septal branches included 1 vessel in 5 patients, 2 vessels in 1 patient and 3 vessels in 1 case. After the procedure, the pressure gradient, evaluated by transthoracic echocardiography, was 34±16 mmHg and 42±12 mmH at 3 month-follow-up. Clinical improvement was recorded in all patients after the procedure (NYHA class I or II). Temporary pacing was necessary in 3 patients during and immediately after the procedure but no patient needed permanent pacing.
Conclusions: Microcoil embolisation is an efficient and safe approach for transcatheter ablation of septal hypertrophy in HOCM. This technique induced myocardial necrosis without the toxic effects of alcohol, reducing the risk of complications such as permanent pacemaker implantation or ethanol flow to other myocardial regions.

Abstract

Background and aim: Percutaneous transcatheter occlusion with ethanol injection of septal arteries is an efficient treatment procedure of hypertrophic obstructive cardiomyopathy (HOCM). The aim of our study was to evaluate the feasibility and efficiency of septal artery embolisation with microcoils.
Methods: Microcoils were delivered through the guide-wire lumen of a 2mm-diameter coaxial balloon positioned inside the target vessel as distally as possible. One or more 0.018"-straight microcoils (Hilal straight coils, Cook, USA) were used for each target vessel until complete flow obstruction was achieved. The intraventricular pressure gradient was measured before, during and after the procedure. Septal branch occlusion was finally documented by coronary angiography.
Results: We treated 7 patients (5 males; mean age: 48±10 years). All patients were symptomatic (NYHA class III or IV). The target vessels were successfully occluded in all patients without complications. Moderate pain was recorded during and after the procedure and the CK level increased five- to ten-fold. The pressure gradient diminished during the procedure from 72±21 mmHg to 30±15 mmHg. The number of coils delivered ranged from 3 to 7 per patient. The embolised septal branches included 1 vessel in 5 patients, 2 vessels in 1 patient and 3 vessels in 1 case. After the procedure, the pressure gradient, evaluated by transthoracic echocardiography, was 34±16 mmHg and 42±12 mmH at 3 month-follow-up. Clinical improvement was recorded in all patients after the procedure (NYHA class I or II). Temporary pacing was necessary in 3 patients during and immediately after the procedure but no patient needed permanent pacing.
Conclusions: Microcoil embolisation is an efficient and safe approach for transcatheter ablation of septal hypertrophy in HOCM. This technique induced myocardial necrosis without the toxic effects of alcohol, reducing the risk of complications such as permanent pacemaker implantation or ethanol flow to other myocardial regions.
Get Citation

Keywords

hypertrophic cardiomyopathy - septal ablation - microcoil embolisation

About this article
Title

Microcoil embolisation for ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 61, No 10 (2004)

Pages

355-355

Published online

2005-12-12

Bibliographic record

Kardiol Pol 2004;61(10):355-355.

Keywords

hypertrophic cardiomyopathy - septal ablation - microcoil embolisation

Authors

Mihai Iacob
Florina Pinte
Ion Tintoiu
Lucretia Cotuna
Mirela Caroescu
Alexandru Popa
Gabriel Cristian
Viorel Goleanu
Vasile Greere
Ion Moscaliuc
Gheorghe Neagoe
Puiu Crisan
Adriana Garjeu
Liviu Chiriac
Romi Bolohan
Vasile Murgu
Beatrice Lobont
Simon Filip
Jean Roates
Gabriel Hila
Elena Postolea

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl